AMERIPRISE FINANCIAL INC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$2,914,585
-57.0%
311,055
+12.6%
0.00%
-50.0%
Q2 2023$6,774,033
-4.1%
276,153
-9.0%
0.00%0.0%
Q1 2023$7,063,352
-9.1%
303,539
-1.1%
0.00%
-33.3%
Q4 2022$7,768,000
-30.2%
306,925
-46.8%
0.00%
-25.0%
Q3 2022$11,132,000
+38.4%
577,377
+82.8%
0.00%
+33.3%
Q2 2022$8,045,000
+1652.7%
315,898
+1667.2%
0.00%
Q1 2022$459,000
-23.0%
17,876
+25.6%
0.00%
Q4 2021$596,000
+2.6%
14,232
+6.6%
0.00%
Q3 2021$581,000
-9.4%
13,352
-1.5%
0.00%
Q2 2021$641,000
-7.0%
13,552
+0.8%
0.00%
Q1 2021$689,00013,4470.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders